New drug could let some rectal cancer patients skip chemotherapy, radiation and surgery
Some people with rectal cancer may now be able to skip chemotherapy, radiation and surgery. The U.S. Food and Drug Administration (FDA) on Monday approved the immunotherapy Jemperli (dostarlimab-gxly) for certain adults with rectal cancer that hasn't been treated yet.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Rice, fish and pickles: Is the traditional Japanese diet as healthy as we think?
United Kingdom
-
Five at-home strength moves that can make everyday tasks easier
United Kingdom
-
Scientists found a link between Mediterranean diet blood markers and longer survival
United Kingdom
-
Would subsidizing weight-loss drugs make health care fairer?
United Kingdom
-
Fitness tracker data could offer clues about future brain health
United Kingdom
-
A 20-year study of 90,000 adults suggests the type of fish you eat matters
United Kingdom
-
Researchers warn of growing threats to sleep health across Europe
United Kingdom
-
Nearly 1.6 million pounds of hot dogs, bacon and deli meats recalled after cooler failure
United Kingdom